Work

Discovery of the First N-Substituted 4β-Methyl-5-(3-hydroxyphenyl)morphan To Possess Highly Potent and Selective Opioid δ Receptor Antagonist Activity

Year: 2003

Type: article

Source: Journal of Medicinal Chemistry

DOI: 10.1021/jm030419a

Authors: F. Ivy Carroll, Li Zhang, S. Wayne Mascarella, Hernán A. Navarro, Richard B. Rothman, Buddy E. Cantrell, Dennis M. Zimmerman, James B. Thomas

Institutions: National Institutes of Health, National Institute on Drug Abuse, Eli Lilly (United States), RTI International

Language: English

Topic: Neuropeptides and Animal Physiology

Subfield: Cellular and Molecular Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institute on Drug Abuse

Awards: G3861717303, Selective Opioid Antagonists as Medications for Drug Abuse

OpenAlex ID: W2060491949

FWCI: 0.346

Cites: 20

Cited by: 15

Related to: 10